Uterine carcinosarcoma in association with tamoxifen therapy.
McCluggage
W G
WG
Department of Pathology, Royal Group of Hospitals Trust, Belfast, UK.
McManus
D T
DT
Lioe
T F
TF
Hill
C M
CM
D000368:Aged; D000369:Aged, 80 and over; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy; D002296:Carcinosarcoma / Q000139:chemically induced* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008408:Mastectomy; D017698:Postmenopause; D013629:Tamoxifen / Q000009:adverse effects*; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000473:pathology
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen